[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enovis Corp (ENOV)

Enovis Corp (ENOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,398,205
  • Shares Outstanding, K 57,563
  • Annual Sales, $ 2,248 M
  • Annual Income, $ -1,184 M
  • EBIT $ 153 M
  • EBITDA $ 1,497 M
  • 60-Month Beta 1.41
  • Price/Sales 0.67
  • Price/Cash Flow 0.97
  • Price/Book 1.02

Options Overview Details

View History
  • Implied Volatility 62.91% (-0.57%)
  • Historical Volatility 65.21%
  • IV Percentile 33%
  • IV Rank 31.76%
  • IV High 109.75% on 02/02/26
  • IV Low 41.11% on 06/20/25
  • Expected Move (DTE 32) 1.11 (4.55%)
  • Put/Call Vol Ratio 0.34
  • Today's Volume 216
  • Volume Avg (30-Day) 178
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 11,545
  • Open Int (30-Day) 10,247
  • Expected Range 23.19 to 25.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.83
  • Number of Estimates 2
  • High Estimate $0.84
  • Low Estimate $0.82
  • Prior Year $0.79
  • Growth Rate Est. (year over year) +5.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.14 +9.71%
on 04/23/26
27.89 -12.91%
on 05/08/26
-1.04 (-4.11%)
since 04/15/26
3-Month
21.40 +13.50%
on 03/20/26
27.89 -12.91%
on 05/08/26
+2.52 (+11.58%)
since 02/13/26
52-Week
21.00 +15.67%
on 01/29/26
36.82 -34.03%
on 07/10/25
-11.44 (-32.02%)
since 05/15/25

Most Recent Stories

More News
1 Small-Cap Stock to Target This Week and 2 We Turn Down

1 Small-Cap Stock to Target This Week and 2 We Turn Down

ENOV : 24.29 (-7.01%)
HIMS : 25.05 (+3.34%)
LFST : 7.65 (-3.04%)
3 Russell 2000 Stocks We’re Skeptical Of

3 Russell 2000 Stocks We’re Skeptical Of

ENOV : 24.29 (-7.01%)
AMRC : 33.03 (-0.75%)
AI : 8.65 (-4.21%)
Enovis Q1 Earnings Call Highlights

Enovis (NYSE:ENOV) reported a solid start to 2026, with management pointing to share gains in its reconstructive surgery business, stable growth in prevention and recovery, and continued investment in...

ENOV : 24.29 (-7.01%)
Why Is Enovis (ENOV) Stock Rocketing Higher Today

Why Is Enovis (ENOV) Stock Rocketing Higher Today

ENOV : 24.29 (-7.01%)
Enovis: Q1 Earnings Snapshot

Enovis: Q1 Earnings Snapshot

ENOV : 24.29 (-7.01%)
Enovis (NYSE:ENOV) Exceeds Q1 CY2026 Expectations

Enovis (NYSE:ENOV) Exceeds Q1 CY2026 Expectations

ENOV : 24.29 (-7.01%)
Enovis Announces First Quarter 2026 Results

First-quarter sales growth of 5% on a reported basis First-quarter Reconstructive sales grew 11% on a reported basis Reiterating full-year 2026 revenue, adjusted EBITDA, adjusted EPS, and Free Cash...

ENOV : 24.29 (-7.01%)
Enovis Reports Tomorrow With Analysts Already Walking Back Their Estimates

Barchart Research What to Expect from ENOV Earnings ENOV Generated May 6, 2026 Current Price $24.85 EPS Estimate $$0.82 Consensus Rating Strong Buy Average Move 7.53% Enovis Reports Tomorrow With Analysts...

ENOV : 24.29 (-7.01%)
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For

Enovis (ENOV) Q1 Earnings Report Preview: What To Look For

ENOV : 24.29 (-7.01%)
1 of Wall Street’s Favorite Stock on Our Buy List and 2 Facing Headwinds

1 of Wall Street’s Favorite Stock on Our Buy List and 2 Facing Headwinds

ENOV : 24.29 (-7.01%)
NOW : 95.07 (+5.05%)
CBRE : 129.95 (-1.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 28.16
2nd Resistance Point 27.20
1st Resistance Point 25.74
Last Price 24.29
1st Support Level 23.32
2nd Support Level 22.36
3rd Support Level 20.90

See More

52-Week High 36.82
Fibonacci 61.8% 30.78
Fibonacci 50% 28.91
Fibonacci 38.2% 27.04
Last Price 24.29
52-Week Low 21.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.